Open Seminar: Available now - COVID-19 monitoring, Dr Jeffrey Barrett

How genome sequencing of COVID-19 virus samples in the UK is helping to guide public health response

Hear how the Sanger Institute has sequenced more than 100,000 SARS-CoV-2 genomes, and how the COVID-19 Genomics UK (COG-UK) Consortium is using the data for surveillance, including the discovery and spread of the B.1.1.7 variant.

Dr Jeffrey Barrett, Director of the COVID-19 Genomics Initiative at the Wellcome Sanger Institute, outlines how the Institute's genome sequencing and analysis expertise is being used to track the rise and spread of new variants of the coronavirus.

Watch our freely available talk now

Sanger Seminar Series

COVID-19 research at the Sanger Institute

We are committed to tracking, understanding and combatting COVID-19. Our staff sequence thousands of virus genomes and use the data to trace transmission, inform public health measures and monitor for new variants of the virus. We also work to understand how the virus interacts with our cells, and to develop new diagnostics

COVID-19 Research